How many investments has Birk Venture made?

Birk Venture has 11 tracked investments, 1 of which have exited.

What stage does Birk Venture invest at?

Birk Venture invests at the Seed, Series A, Series B, Growth stages.

What sectors does Birk Venture focus on?

Birk Venture focuses on Biotech, Healthtech, Medical Devices, Wellness & Fitness.

Where is Birk Venture located?

Birk Venture is headquartered in Oslo, NO.

Birk Venture

Venture capital

Oslo · Seed–Growth · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Birk Venture

454 people in our graph share verified history with the Birk Venture team — schools, employers, funds. One of them is your warm intro.

Miguel Forteunlockedknows Hans Ivar Robinson · together at Zelluna Immunotherapy (overlapped)

×6knows the team · via Practica Capital

×5knows the team · via Pfizer

✨ Fox Verdict

Investment thesis

Birk Venture is a private evergreen investment company that invests exclusively in the life science sector, backing young companies with significant growth potential across pharmaceuticals, biotechnology, diagnostics, medical devices, and consumer health. It invests in both early-stage and more developed companies, seeking innovative technologies that address clear global medical needs, have achieved proof of concept or strong scientific acceptance, and are led by strong management and founders. The firm takes an active, long-term role in developing its portfolio companies, drawing on deep industrial experience from the pharmaceutical and biotech industry. Deal flow comes from universities, start-ups, spin-offs, and co-investors through a private investment consortium.

Invests inBiotech Healthtech Medical Devices Wellness & Fitness Europe Norway Oslo

Source: firm website, verified Sep 26, 2026.

Stage

Seed–Growth

Oslo, NO

Instruments

Equity

Founded

2010

Tracked investments

Unicorns

Acquisitions

Team · 2 people

from the firm's website & public directories

Hans Ivar Robinson· CEO/Chairman· Oslo, Oslo, Norwayin

Founder of Birk Venture (2010) with 25 years of experience in the pharmaceutical and biotech industry, including leadership roles at AstraZeneca, Pfizer and Pronova Biopharma. He has extensive experience with capital raising, private placements, mergers and IPOs, and holds an M.Sc. from the Norwegian School of Economics (NHH).

h•••@birkventure.noreveal

Per-Oluf Olsen· Co-investor and external partner

Has 27 years of experience in the pharmaceutical and biotech industry with top management roles at Pfizer, including country manager for Norway/Denmark and Italy and regional executive director for Central and Eastern Europe, and later served as CEO of Pronova BioPharma AS.

What they invest in

from 7 of 11 portfolio companies

Biotech ×6Healthtech ×3Deep Tech ×2Medical Devices ×2Advanced Manufacturing ×1AI & Machine Learning ×1Developer Tools ×1E-commerce ×1

HQs:Norway×3

Investments · 11 tracked

founders shown can be your intro path

Accession Therapeuticsaccessiontherapeutics.com inApr 2024

Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies.

BiotechHealthtechMedical Devices

Alan Parker(CSO and Founder of Trocept)inBent Jakobsen(CEO and Founder)in

Co-investorsiGlobe Partners

Algetaalgeta.comacquired by Bayer · Dec 2013 · $2.9B

Algeta was a Norwegian oncology company developing alpha-particle radiopharmaceuticals, notably Xofigo (radium-223 dichloride) for bone metastases in prostate cancer.

Co-investorsAdvent Life Sciences HealthCap Abingworth

APIM Therapeuticsapimtherapeutics.com

APIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting peptide therapeutics that disrupt cellular stress responses and address treatment resistance in cancer.

BiotechHealthtech

Co-investorsSarsia Management AS

BerGenBiobergenbio.com

BerGenBio ASA was a company that merged with Oncoinvent ASA on 29 October 2025, with the combined entity renamed Oncoinvent.

Biotech

Co-investorsSarsia Management AS Investinor

Kloner ASkloner.no

Kloner is a Norwegian web operations and e-commerce company that designs, builds, and operates digital platforms for small and medium-sized businesses.

AI & Machine LearningDeveloper ToolsE-commerceEnterprise SoftwareSaaSOslo, NO

Rune Christensen(Founder)in

Nexteranextera.no

Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases.

BiotechDeep Tech

PCI Biotechpcibiotech.no

PCI Biotech develops bioprocessing technologies for manufacturing viral vectors and intracellular drug delivery solutions, serving immunotherapy and dermatology applications.

Advanced ManufacturingBiotechMedical DevicesOslo, NO

Targovaxtargovax.com

Circio is a biotech company developing circular RNA technology (circVec) to improve AAV gene therapy expression for the treatment of genetic diseases.

BiotechDeep TechHealthtech

Co-investorsHealthCap

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Cortendo ABNordic Nanovector ASZelluna Immunotherapy

Exits · 1

1 acquisitions

Algetaacq. by Bayer

Portfolio news

latest coverage across their companies

Accession Therapeutics awarded €7.5m Horizon Europe grant funding to advance TROCEPT-01 (ATTR-01), a first-in-class, tumour-activated immunotherapy

Accession Therapeutics · accessiontherapeutics.com · Mar 24, 2026

PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options

PCI Biotech · finance.yahoo.com · Jan 8, 2026

Frequently asked questions

How many investments has Birk Venture made?: Birk Venture has 11 tracked investments, 1 of which have exited.
What stage does Birk Venture invest at?: Birk Venture invests at the Seed, Series A, Series B, Growth stages.
What sectors does Birk Venture focus on?: Birk Venture focuses on Biotech, Healthtech, Medical Devices, Wellness & Fitness.
Where is Birk Venture located?: Birk Venture is headquartered in Oslo, NO.

Similar investors

ACT Venture Capital

ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.

$1.1M – $16.2M

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M